Infinera Corp
—- Market cap
- —
- Debt
- +$668.41M
- Cash
- −$145.81M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: INFN stock price vs HRMY: inconclusive — current versus $16.89 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at HRMY's multiple
Implied fair value · at INFN's multiple
Needs INFN P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: INFN FY 2024 (ended Dec 28, 2024) · HRMY FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 94% equity / 6% debt · EV / Revenue 2.13x · EV / EBITDA 7.27x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Infinera Corp · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
HARMONY BIOSCIENCES HOLDINGS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
5.74x
0.19x
Net debt / EBITDA
Leverage against operating earnings
-11.94x
-2.41x
Cash and equivalents
Liquid reserves on the balance sheet
$145.81M
$775.34M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
CIENA CORP
INFN vs CIEN
VIAVI SOLUTIONS INC.
INFN vs VIAV
JUNIPER NETWORKS INC
INFN vs JNPR
CISCO SYSTEMS, INC.
INFN vs CSCO
Arista Networks, Inc.
INFN vs ANET
Motorola Solutions, Inc.
INFN vs MSI
Jazz Pharmaceuticals plc
INFN vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
INFN vs SUPN
Intra-Cellular Therapies, Inc.
INFN vs ITCI
ACADIA PHARMACEUTICALS INC
INFN vs ACAD
Vanda Pharmaceuticals Inc.
INFN vs VNDA
LivaNova PLC
INFN vs LIVN
$668.41M
$163.66M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.